Mark Sirgo
Chief Executive Officer chez Corium Pharma Solutions, Inc.
Fortune : 121 877 $ au 31/03/2024
Profil
Dr. Mark A.
Sirgo is a Chief Executive Officer & Director at Corium Pharma Solutions, Inc. and a Chairman at RDD Pharma Ltd.
He is on the Board of Directors at Corium Pharma Solutions, Inc. Dr. Sirgo was previously employed as a Chairman by Genenta Science SpA, a Chairman by 9 Meters Biopharma, Inc., a Chief Executive Officer & Director by Aruna Bio, Inc., an Independent Director by Biomerica, Inc., an Independent Director by Salix Pharmaceuticals Ltd., a Vice Chairman by BioDelivery Sciences International, Inc., a Chief Executive Officer by Arius Pharmaceuticals, Inc., a Senior Vice President-Global Sales & Marketing by Pharmaceutical Product Development LLC, a Vice President-New Product Marketing by Glaxo Wellcome, Inc., a Vice President-New Product Marketing by Glaxo, Inc., and a Vice President-New Product Marketing by GSK Plc.
He received his undergraduate degree from The Ohio State University and a doctorate degree from Philadelphia College of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENENTA SCIENCE SPA
0,19% | 19/04/2023 | 34 822 ( 0,19% ) | 121 877 $ | 31/03/2024 |
9 METERS BIOPHARMA, INC.
0,57% | 24/04/2023 | 83 040 ( 0,57% ) | - $ | 31/03/2024 |
Postes actifs de Mark Sirgo
| Sociétés | Poste | Début |
|---|---|---|
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Chairman | 04/06/2018 |
Corium Pharma Solutions, Inc.
 Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Chief Executive Officer | 17/01/2023 |
Anciens postes connus de Mark Sirgo
| Sociétés | Poste | Fin |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Chairman | 17/07/2023 |
| BIOMERICA, INC. | Director/Board Member | 07/12/2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Chief Executive Officer | 02/01/2018 |
| SALIX PHARMACEUTICALS, LTD. | Director/Board Member | 01/04/2015 |
Arius Pharmaceuticals, Inc.
 Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arius Pharmaceuticals, Inc. develops pharmaceuticals for surgical and oncology patients. The firm offers treatments for rapid, oral delivery of sedation, and pain relief of surgical and oncology patients. The firm was founded by Andrew Finn and Mark A. Sirgo in 2003 and is located in Morrisville, NC | Chief Executive Officer | 01/08/2004 |
Formation de Mark Sirgo
| The Ohio State University | Undergraduate Degree |
| Philadelphia College of Pharmacy | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMERICA, INC. | Health Technology |
| GSK PLC | Health Technology |
| GENENTA SCIENCE S.P.A. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Pharmaceutical Product Development LLC
 Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Arius Pharmaceuticals, Inc.
Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arius Pharmaceuticals, Inc. develops pharmaceuticals for surgical and oncology patients. The firm offers treatments for rapid, oral delivery of sedation, and pain relief of surgical and oncology patients. The firm was founded by Andrew Finn and Mark A. Sirgo in 2003 and is located in Morrisville, NC | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| Glaxo, Inc. | |
Aruna Bio, Inc.
 Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
| 9 Meters Biopharma, Inc. | |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023. | Commercial Services |
